Literature DB >> 19264778

Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes.

Roger D Everett1, Marie-Laure Parsy, Anne Orr.   

Abstract

Herpes simplex virus type 1 (HSV-1) immediate-early regulatory protein ICP0 is important for stimulating the initiation of the lytic cycle and efficient reactivation of latent or quiescent infection. Extensive investigation has suggested several potential functions for ICP0, including interference in the interferon response, disruption of functions connected with PML nuclear bodies (ND10), and inhibition of cellular histone deacetylase (HDAC) activity through an interaction with the HDAC-1 binding partner CoREST. Analysis of the significance of these potential functions and whether they are direct or indirect effects of ICP0 is complicated because HSV-1 mutants expressing mutant forms of ICP0 infect cells with widely differing efficiencies. On the other hand, transfection approaches for ICP0 expression do not allow studies of whole cell populations because of their limited efficiency. To overcome these problems, we have established a cell line in which ICP0 expression can be induced at levels pertaining during the early stages of HSV-1 infection in virtually all cells in the culture. Such cells enable 100% complementation of ICP0-null mutant HSV-1. Using cells expressing the wild type and a variety of mutant forms of ICP0, we have used this system to analyze the role of defined domains of the protein in stimulating lytic infection and derepression from quiescence. Activity in these core functions correlated well the ability of ICP0 to disrupt ND10 and inhibit the recruitment of ND10 proteins to sites closely associated with viral genomes at the onset of infection, whereas the CoREST binding region was neither sufficient nor necessary for ICP0 function in lytic and reactivating infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264778      PMCID: PMC2682082          DOI: 10.1128/JVI.02593-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  88 in total

1.  The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.

Authors:  Haidong Gu; Bernard Roizman
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

2.  The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.

Authors:  W Cai; T L Astor; L M Liptak; C Cho; D M Coen; P A Schaffer
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

3.  Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus.

Authors:  D M Ciufo; M A Mullen; G S Hayward
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

4.  A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner.

Authors:  R D Everett; A Cross; A Orr
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

5.  Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).

Authors:  G G Maul; H H Guldner; J G Spivack
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

6.  The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.

Authors:  Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-10       Impact factor: 11.205

7.  Glutamine deprivation causes enhanced plating efficiency of a herpes simplex virus type 1 ICP0-null mutant.

Authors:  Ryan M Bringhurst; Antonia A Dominguez; Priscilla A Schaffer
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  Herpes simplex virus type 1 regulatory protein ICP0 aids infection in cells with a preinduced interferon response but does not impede interferon-induced gene induction.

Authors:  Roger D Everett; Anne Orr
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

9.  Induction of cellular stress overcomes the requirement of herpes simplex virus type 1 for immediate-early protein ICP0 and reactivates expression from quiescent viral genomes.

Authors:  Chris M Preston; Mary Jane Nicholl
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

10.  Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection.

Authors:  Anna R Cliffe; David M Knipe
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

View more
  64 in total

1.  Herpes simplex virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation.

Authors:  Claus-Henning Nagel; Nina Albrecht; Kristijana Milovic-Holm; Lakshmikanth Mariyanna; Britta Keyser; Bettina Abel; Britta Weseloh; Thomas G Hofmann; Martha M Eibl; Joachim Hauber
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  Depletion of intracellular zinc inhibits the ubiquitin ligase activity of viral regulatory protein ICP0 and restricts herpes simplex virus 1 replication in cell culture.

Authors:  Kyle Grant; Louise Grant; Lily Tong; Chris Boutell
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 4.  Virion factors that target Daxx to overcome intrinsic immunity.

Authors:  Sabrina Schreiner; Harald Wodrich
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

5.  APOBEC3A damages the cellular genome during DNA replication.

Authors:  Abby M Green; Sébastien Landry; Konstantin Budagyan; Daphne C Avgousti; Sophia Shalhout; Ashok S Bhagwat; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

6.  Development of a novel cell-based assay to monitor the transactivation activity of the HSV-1 protein ICP0.

Authors:  Angela M Fowler; Heather E Shinogle; David J Davido
Journal:  Antiviral Res       Date:  2015-04-30       Impact factor: 5.970

7.  A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Chris Boutell; Sebastien Landry; Junghae Suh; Stephanie Panier; Roger D Everett; Grant S Stewart; Daniel Durocher; Matthew D Weitzman
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

8.  Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.

Authors:  Mandy Glass; Roger D Everett
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.

Authors:  Kathryne E Taylor; Marianne V Chew; Ali A Ashkar; Karen L Mossman
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture.

Authors:  Omar Flores; Sanae Nakayama; Adam W Whisnant; Hassan Javanbakht; Bryan R Cullen; David C Bloom
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.